Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis.
J Dtsch Dermatol Ges. 2024 Feb;22(2):278-281. doi: 10.1111/ddg.15292. Epub 2024 Jan 7.
J Dtsch Dermatol Ges. 2024.
PMID: 38185772
No abstract available.
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment.
Leutz A, Pinter A, Thaçi D, Augustin M, Schuster C, Fotiou K, Hundemer HP, Saure D, Mrowietz U, Reich K.
Leutz A, et al. Among authors: fotiou k.
Br J Dermatol. 2021 Mar;184(3):548-550. doi: 10.1111/bjd.19558. Epub 2020 Nov 10.
Br J Dermatol. 2021.
PMID: 32940343
No abstract available.
Item in Clipboard
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks.
Egeberg A, Kristensen LE, Puig L, Rich P, Smith SD, Garrelts A, See K, Holzkaemper T, Fotiou K, Schuster C.
Egeberg A, et al. Among authors: fotiou k.
J Dermatolog Treat. 2023 Dec;34(1):2263108. doi: 10.1080/09546634.2023.2263108. Epub 2023 Oct 2.
J Dermatolog Treat. 2023.
PMID: 37781881
Free article.
Item in Clipboard
Ixekizumab im Vergleich zu Fumarsäureestern und Methotrexat bei der Behandlung der Nagelpsoriasis bei Patienten mit mittelschwerer bis schwerer Psoriasis: Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis.
Augustin M, Mrowietz U, Willsmann-Theis D, Gerdes S, Fotiou K, Schuster C, Mert C, Holzkaemper T, Behrens F, Pinter A.
Augustin M, et al. Among authors: fotiou k.
J Dtsch Dermatol Ges. 2024 Feb;22(2):278-282. doi: 10.1111/ddg.15292_g.
J Dtsch Dermatol Ges. 2024.
PMID: 38361190
No abstract available.
Item in Clipboard
Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO).
Pinter A, Eyerich K, Costanzo A, Garrelts A, Schuster C, Mert C, Lampropoulou A, Fotiou K, Maul JT, Papp KA.
Pinter A, et al. Among authors: fotiou k.
J Dermatolog Treat. 2024 Dec;35(1):2350227. doi: 10.1080/09546634.2024.2350227. Epub 2024 May 26.
J Dermatolog Treat. 2024.
PMID: 38797734
Free article.
Item in Clipboard
Pictorial representation of illness and self measure (PRISM): an effective tool to assess the burden of psoriasis.
Fotiou K, Hofmann M, Kaufmann R, Thaci D.
Fotiou K, et al.
J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2356-62. doi: 10.1111/jdv.13232. Epub 2015 Aug 31.
J Eur Acad Dermatol Venereol. 2015.
PMID: 26332649
Item in Clipboard
Serum ceruloplasmin as a marker in prostate cancer.
Fotiou K, Vaiopoulos G, Lilakos K, Giannopoulos A, Mandalenaki K, Marinos G, Koritsiadis G, Sourdis J, Konstantinidou E, Konstantopoulos K.
Fotiou K, et al.
Minerva Urol Nefrol. 2007 Dec;59(4):407-11.
Minerva Urol Nefrol. 2007.
PMID: 17947957
Item in Clipboard
Cite
Cite